General Information of the Compound
Compound ID
CP0549699
Compound Name
5-bromo-4-[4-[(1-methylimidazol-2-yl)methyl]piperazin-1-yl]-1H-pyridazin-6-one
    Show/Hide
Structure
Formula
C13H17BrN6O
Molecular Weight
353.224
Canonical SMILES
Cn1ccnc1CN1CCN(CC1)c1cn[nH]c(=O)c1Br
    Show/Hide
InChI
InChI=1S/C13H17BrN6O/c1-18-3-2-15-11(18)9-19-4-6-20(7-5-19)10-8-16-17-13(21)12(10)14/h2-3,8H,4-7,9H2,1H3,(H,17,21)
    Show/Hide
InChIKey
SDJSEMKOEAKCCS-UHFFFAOYSA-N
Physicochemical Property
logP
0.5881
Rotatable Bonds
3
Heavy Atom Count
21
Polar Areas
70.05
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 138471830
ChEMBL ID
CHEMBL4590831
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS